Biotech · Private company · Houston, TX, US
VenoStent
Track this companyFree. Adds VenoStent to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SelfWrap Bioabsorbable Perivascular WrapChronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Untreated AVF ControlChronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas StudyNA · RECRUITING · started Jan 3, 2024ClinicalTrials.gov NCT06001827 · fetched Nov 12, 2026
NIH awards7
- Characterization of the Long-Term Degradation of a Novel, Bioabsorbable Perivascular Wrap to Improve Outcomes in Arteriovenous Fistula Creation SurgeryFiscal year 2026 · $404.4KNIH RePORTER 1R33HL185606-01 · fetched Nov 12, 2026
- Pilot-Scale Synthesis for the Commercialization of a Novel, Bioabsorbable Perivascular Wrap to Improve Outcomes in Arteriovenous Fistula Creation and Other Vascular SurgeriesFiscal year 2026 · $1MNIH RePORTER 1R44HL187038-01 · fetched Nov 12, 2026
- Process Validation and Commercialization of SelfWrap, a Bioabsorbable Wrap to Improve Dialysis Access OutcomesFiscal year 2026 · $500KNIH RePORTER 1SB1HL184448-01 · fetched Nov 12, 2026
- SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaSFiscal year 2026 · $1.2MNIH RePORTER 5R44HL151025-04 · fetched Nov 12, 2026
- TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaSFiscal year 2025 · $50KNIH RePORTER 3R44HL151025-03S1 · fetched Nov 12, 2026
- SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaSFiscal year 2025 · $1.2MNIH RePORTER 5R44HL151025-03 · fetched Nov 12, 2026
- SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaSFiscal year 2024 · $1.2MNIH RePORTER 2R44HL151025-02A1 · fetched Nov 12, 2026